Janux Therapeutics, Inc. · NASDAQ:JANX
Janux Therapeutics, Inc. shareholders
As of Jun 30, 2026, 192 institutions reported holding Janux Therapeutics, Inc. Largest: Ra Capital Management, L.P., BlackRock and Prosight Management, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Janux Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 11.2M | no change | Aug 14, 2026 | |
| BlackRock | 6.13M | +701K | Aug 7, 2026 | |
| Prosight Management, LP | 3.8M | +254K | Aug 14, 2026 | |
| Vanguard | 3.56M | +88,063 | Aug 13, 2026 | |
| State Street | 3M | +541K | Aug 7, 2026 | |
| Fidelity | 2.41M | −123K | Aug 13, 2026 | |
| Federated Hermes, Inc. | 2.35M | +2.3M | Aug 12, 2026 | |
| Point72 Asset Management, L.P. | 1.99M | +838K | Aug 14, 2026 | |
| TCG Crossover Management, LLC | 1.79M | no change | Aug 14, 2026 | |
| Alyeska Investment Group, L.P. | 1.65M | +46,051 | Aug 14, 2026 |